Zhanyu Pan Selected Research

Zhanyu Pan Research Topics

Disease

16	Neoplasms (Cancer) 01/2024 - 09/2017
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 02/2017
7	Breast Neoplasms (Breast Cancer) 12/2023 - 12/2014
3	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2017
3	Disease Progression 01/2023 - 10/2020
3	Lung Neoplasms (Lung Cancer) 12/2020 - 12/2017
3	Nasopharyngeal Carcinoma 01/2020 - 04/2015
2	Ascites 04/2023 - 09/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 03/2018
2	Proteinuria 01/2021 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 01/2018
2	Hypoxia (Hypoxemia) 01/2020 - 01/2018
2	Adenocarcinoma 12/2018 - 09/2017
1	Vomiting 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Microsatellite Instability 01/2023
1	Nausea 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Carcinogenesis 09/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 10/2020
1	Esophageal Fistula 10/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Pain (Aches) 01/2018
1	Stomatitis 01/2018
1	Xerostomia 01/2018
1	Mucositis 01/2018
1	Residual Neoplasm 12/2017
1	Carcinoma (Carcinomatosis) 12/2017
1	Medulloblastoma 12/2017

Drug/Important Bio-Agent (IBA)

4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 03/2023 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 09/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 12/2017
3	apatinibIBA 01/2021 - 10/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2023 - 09/2017
2	ErbB Receptors (EGF Receptor)IBA 03/2023 - 01/2023
2	Capecitabine (Xeloda)FDA Link 01/2023 - 12/2018
2	anlotinibIBA 01/2023 - 12/2020
2	CytokinesIBA 07/2022 - 01/2020
2	phosphatidyl-N-monomethylaminoethanolIBA 01/2022 - 03/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2018
2	Therapeutic UsesIBA 01/2021 - 12/2020
2	B7-H1 AntigenIBA 01/2021 - 12/2017
2	Immune Checkpoint InhibitorsIBA 12/2020 - 02/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2017
1	RNA (Ribonucleic Acid)IBA 01/2024
1	AntigensIBA 04/2023
1	CarbohydratesIBA 04/2023
1	Endothelial Growth FactorsIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	QuercetinIBA 01/2023
1	6-methyladenineIBA 09/2022
1	isoliquiritigenin (GU 17)IBA 09/2022
1	N-methyladenosineIBA 09/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	icotinibIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	camrelizumabIBA 01/2021
1	2-tyrosineIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2020
1	baicalinIBA 01/2020
1	rhamnetinIBA 01/2019
1	AnthracyclinesIBA 12/2018
1	taxaneIBA 12/2018
1	thiamine triphosphorate (TTP)IBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2017
1	Caspase 3 (Caspase-3)IBA 12/2017
1	MatrinesIBA 12/2017
1	Gentian Violet (Violet, Crystal)FDA Link 12/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2017
1	ginsenoside Rg3IBA 12/2017
1	pembrolizumabIBA 02/2017
1	Trastuzumab (Herceptin)FDA Link 12/2014
1	human ERBB2 proteinIBA 12/2014
1	Lapatinib (GW572016)FDA Link 12/2014

Therapy/Procedure

9	Therapeutics 03/2023 - 04/2015
5	Drug Therapy (Chemotherapy) 01/2023 - 12/2017
3	Immunotherapy 01/2022 - 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 12/2023
1	Moxibustion 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2018
1	Radiotherapy 01/2018
1	Palliative Care (Palliative Therapy) 09/2017
1	Neoadjuvant Therapy 12/2014